Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric A Toth

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|March 9, 2022
Induction of broadly neutralizing antibodies using a secreted form of the hepatitis C virus E1E2 heterodimer as a vaccine candidateRuixue Wang, Saori Suzuki, Johnathan D Guest, et al.
Journal of Medicinal Chemistry|January 5, 2016
Small Molecule Inhibitors of Ca(2+)-S100B Reveal Two Protein ConformationsMichael C Cavalier, Mohd Imran Ansari, Adam D Pierce, et al.
European Journal of Medicinal Chemistry|March 18, 2016
Structure-based design of N-substituted 1-hydroxy-4-sulfamoyl-2-naphthoates as selective inhibitors of the Mcl-1 oncoproteinMaryanna E Lanning, Wenbo Yu, Jeremy L Yap, et al.
Nature Communications|February 11, 2026
Native-like soluble E1E2 glycoprotein heterodimers on self-assembling protein nanoparticles for hepatitis C virus vaccine designLinling He, Yi-Zong Lee, Yi-Nan Zhang, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2025
Native-like soluble E1E2 glycoprotein heterodimers on self-assembling protein nanoparticles for hepatitis C virus vaccine designLinling He, Yi-Zong Lee, Yi-Nan Zhang, et al.
Biorxiv : the Preprint Server for Biology|January 16, 2026
mAbClust with AlphaFold 3 avoids hallucinations to define a quaternary broadly neutralizing HCV epitopeHarry T Paul, Jessica L Mimms, Hanna Aboueid, et al.
Journal of Virology|September 4, 2020
Structure-Based Design of Hepatitis C Virus E2 Glycoprotein Improves Serum Binding and Cross-NeutralizationBrian G Pierce, Zhen-Yong Keck, Ruixue Wang, et al.
Communications Biology|March 6, 2021
Engineering subtilisin proteases that specifically degrade active RASYingwei Chen, Eric A Toth, Biao Ruan, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 12, 2021
Design of a native-like secreted form of the hepatitis C virus E1E2 heterodimerJohnathan D Guest, Ruixue Wang, Khadija H Elkholy, et al.
Biorxiv : the Preprint Server for Biology|December 31, 2025
B cell transcriptomics reveals lasting dysregulation and rapid decline of protective memory after hepatitis C cureFang Chen, Erick Giang, Padmaja Natarajan, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Proceedings of the National Academy of Sciences of the United States of America|March 9, 2022
Induction of broadly neutralizing antibodies using a secreted form of the hepatitis C virus E1E2 heterodimer as a vaccine candidateRuixue Wang, Saori Suzuki, Johnathan D Guest, et al.
Journal of Medicinal Chemistry|January 5, 2016
Small Molecule Inhibitors of Ca(2+)-S100B Reveal Two Protein ConformationsMichael C Cavalier, Mohd Imran Ansari, Adam D Pierce, et al.
European Journal of Medicinal Chemistry|March 18, 2016
Structure-based design of N-substituted 1-hydroxy-4-sulfamoyl-2-naphthoates as selective inhibitors of the Mcl-1 oncoproteinMaryanna E Lanning, Wenbo Yu, Jeremy L Yap, et al.
Nature Communications|February 11, 2026
Native-like soluble E1E2 glycoprotein heterodimers on self-assembling protein nanoparticles for hepatitis C virus vaccine designLinling He, Yi-Zong Lee, Yi-Nan Zhang, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2025
Native-like soluble E1E2 glycoprotein heterodimers on self-assembling protein nanoparticles for hepatitis C virus vaccine designLinling He, Yi-Zong Lee, Yi-Nan Zhang, et al.
Biorxiv : the Preprint Server for Biology|January 16, 2026
mAbClust with AlphaFold 3 avoids hallucinations to define a quaternary broadly neutralizing HCV epitopeHarry T Paul, Jessica L Mimms, Hanna Aboueid, et al.
Journal of Virology|September 4, 2020
Structure-Based Design of Hepatitis C Virus E2 Glycoprotein Improves Serum Binding and Cross-NeutralizationBrian G Pierce, Zhen-Yong Keck, Ruixue Wang, et al.
Communications Biology|March 6, 2021
Engineering subtilisin proteases that specifically degrade active RASYingwei Chen, Eric A Toth, Biao Ruan, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 12, 2021
Design of a native-like secreted form of the hepatitis C virus E1E2 heterodimerJohnathan D Guest, Ruixue Wang, Khadija H Elkholy, et al.
Biorxiv : the Preprint Server for Biology|December 31, 2025
B cell transcriptomics reveals lasting dysregulation and rapid decline of protective memory after hepatitis C cureFang Chen, Erick Giang, Padmaja Natarajan, et al.
Pageof 6